Stem cell therapy: A cure or curse



Stem cells are broadly defined as cells with the ability to differentiate into a number of specialised tissues. There are at least 2 kinds of stem cells: haematopoietic stem cells, which form all types of blood cells in the body; and mesenchymal stem cells (MSC), which can generate bone, cartilage and fat cells that support the formation of blood and fibrous connective tissue.[1] Stem cell transplantation (SCT) includes the transplantation of both of
these cell types. Haematopoietic stem cell transplantation (HSCT) refers to the infusion of hematopoietic
stem cells into a patient, typically obtained from peripheral blood or bone marrow.[1] HSCTs are classified as either allogeneic when sourced from a matching donor, or autologous when stem cells from the patient are used. MSC therapy uses cells from bone marrow, adipose, muscle, peripheral blood or the umbilical cord; however, the application of MSCs has been associated with variable clinical outcomes.[2]

How to Cite
Phan, T. H. T. (Rose). (2019). Stem cell therapy: A cure or curse . AMSA Journal of Global Health, 13(2), 47-52. Retrieved from
Feature Articles